At ASCO 2025, attendees see reason for hope, despite worries AstraZeneca’s plenary streak continues and Pfizer acquired a $1.25 billion antibody.

https://www.statnews.com/2025/05/30/asco-2025-pfizer-astrazeneca-daiichi-sankyo-summit-cancer-news/